Live Science on MSN19h
Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
New Atlas13h
Gold outperforms Ozempic for weight loss – and leaves muscles alone
There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...
WDRB19h
The 2 sides of Ozempic — weight loss success stories and health nightmares in Kentucky
The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...
Hosted on MSN9h
Wegovy and Ozempic stars dim amid overuse concerns
The luster is starting to wear off GLP-1 weight-loss drugs including Wegovy and Ozempic as more clinicians warn patients ...